Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

418 Press Releases
DateTitleCompany
10 Apr 13 Mercodia and Profil Institute Announce Partnership Offering Insulin and Metabolism ELISA Assays to Enhance Diabetes and Obesity Clinical Trials Mercodia AB
10 Apr 13 ARIAD PRESENTS NEW PRECLINICAL DATA SHOWING PONATINIB OVERCOMES RESISTANT MUTATIONS IN KIT, AN ONCOGENIC DRIVER OF GASTROINTESTINAL STROMAL TUMORS ARIAD Pharmaceuticals, Inc,
Published by
Biosector 2
09 Apr 13 The Canadian pharmaceutical company Duchesnay Inc. sets for international expansion following the US approval of its morning sickness medication Diclegis® by the FDA Duchesnay inc.,
Published by
PR Newswire
09 Apr 13 Isansys Lifecare announces next-stage funding to speed in-hospital wireless patient monitoring to whole patient populations Isansys
08 Apr 13 New PDUFA action date announced by the US FDA for Injectafer® New Drug Application Vifor Pharma ,
Published by
Vifor Pharma
08 Apr 13 Lundbeck announces positive results for Brintellix™ (vortioxetine) in adult patients with major depression and inadequate response to SSRI or SNRI therapy H. Lundbeck A/S,
Published by
Lundbeck
08 Apr 13 Katrina Kaif, Virat Kohli, Kiran Bedi, Jaipal Ramesh, Shailendra Singh are in the Race for Brand Icon of The Year 2013 Pharmaleaders,
Published by
http://www.pharmaleaders.co.in
02 Apr 13 SUNOVION EUROPE ANNOUNCES NEW NAME Sunovion Pharmaceuticals Europe Ltd,
Published by
Munro & Forster
02 Apr 13 Update on Developmental and Clinical Activity ValiRx Plc,
Published by
ValiRx plc
02 Apr 13 Clavis Pharma announces negative outcome of Phase III CLAVELA trial with elacytarabine in patients with acute myeloid leukaemia Clavis Pharma
01 Apr 13 4th Annual India Leadership Conclave & Indian Affairs Business Leadership Award 2013 Nominations Announced Pharmaleaders,
Published by
http://www.pharmaleaders.tv
27 Mar 13 NICE has recently recommended omalizumab (Xolair, Novartis Pharmaceuticals UK) as an option for treating severe, persistent allergic asthma in adults, adolescents and children. The SMi Group ,
Published by
SMi Group Ltd
26 Mar 13 Shire to Acquire SARcode Bioscience, Expands Presence in Ophthalmology Shire ,
Published by
Shire
26 Mar 13 SAFEWARE QUASAR EXHIBITS AT CHEMSPEC EUROPE Safeware Quasar
26 Mar 13 Lundbeck and Otsuka further expand their alliance and enter into collaboration for the development and commercialization of Lu AE58054 in development for Alzheimer’s disease H. Lundbeck A/S ,
Published by
Lundbeck
26 Mar 13 Three Plenary Keynotes to Take Place at 12th Annual Bio-IT World Expo Cambridge Healthtech Institute
26 Mar 13 Recipharm site in France approved for supply of manufactured products to Japan Recipharm AB,
Published by
DeFacto
25 Mar 13 Fight back against MRSA to be started with a sniff Procarta Biosystems
25 Mar 13 Results of St. Jude Medical’s RESPECT Trial Published in The New England Journal of Medicine St. Jude Medical, Inc,
Published by
Chandler Chicco Agency
25 Mar 13 A new look for the Cetraben range of products for the treatment of dry skin and eczema Genus Pharmaceuticals ,
Published by
Packer Forbes Communications
25 Mar 13 Luke Johnson, leading entrepreneur, takes the helm at The Institute of Cancer Research The Institute of Cancer Research
22 Mar 13 ClinTec chosen for insight into global networking techniques in the world of international business ClinTec International,
Published by
DeFacto
22 Mar 13 EUROPEAN CHMP ADOPTS POSITIVE OPINION FOR STRIBILD®, A ONCE-DAILY, INTEGRASE INHIBITOR-BASED, SINGLE TABLET REGIMEN FOR THE TREATMENT OF HIV-1 INFECTION Gilead Sciences
22 Mar 13 Results of St. Jude Medical’s RESPECT Trial Published in The New England Journal of Medicine St. Jude Medical
22 Mar 13 Valeant Pharmaceuticals International, Inc. Agrees to Acquire Obagi Medical Products, Inc. Valeant Pharmaceuticals International, Inc
21 Mar 13 Almac’s Clinical Trial Workshop Series to Return in 2013 Almac Group,
Published by
DeFacto
21 Mar 13 Boehringer-Ingelheim, Roche, Novartis to discuss regulatory challenges occurring in emerging markets for Supply Chain at SMi’s Clinical Trial Logistics SMi Group
20 Mar 13 REAL WORLD STUDY COMPARING COMMONLY PRESCRIBED COPD MEDICINES SHOWS CHOICE OF TREATMENT HAS IMPACT ON PATIENT OUTCOMES AstraZeneca
20 Mar 13 STEVANATO GROUP DOUBLES SIZE OF MEXICO PLANT. STEVANATO GROUP
20 Mar 13 Spring Ahead: Prevent Lyme Disease ERELEASES,
Published by
PR Newswire
Advertising